Mumbai: IT major, Tata Consultancy Services (TCS) announced the has launch of TCS ADDAgentHub, a role-based, enterprise-ready platform that enables the use of agentic AI in drug development at scale.
The platform enables pharma companies to deploy an operating model in which AI agents are embedded into enterprise workflows, with humans retaining responsibility for governing and decision‑making.
Companies can custom build their AI agent hub and deploy them across clinical workflows.
TCS said the platform has demonstrated up to 40 per cent efficiency gains in clinical data management activities, up to 30 per cent reduction in clinical study build effort through metadata-driven automation, and up to 30 per cent cost savings in end-to-end safety case processing.
AI-powered safety agents can also reduce quality control effort by helping organizations improve productivity across critical R&D processes, it added.
“The platform enables a shift from reactive to proactive, scalable, and audit-ready operations amidst an ever-changing regulatory environment. TCS’ strategy is to move towards autonomous enterprise functions where AI agentic workforce operates alongside humans driving innovation in drug development and improving patient safety,” said Debashis Ghosh, President, Lifesciences and Healthcare, TCS.
Notably, the IT services provider is facing mounting pressure amid the rapid rise of AI, which threatens to automate many of the services it currently provides and is racing to recast its business model to become the “world’s largest AI-led technology services company.”
Published On Aug 18, 2026 at 07:43 AM IST
Join the community of 2M+ industry professionals.
Subscribe to Newsletter to get latest insights & analysis in your inbox.
All about ETPharma industry right on your smartphone!
